Organization Overview
Alternative names
bevacizumab (avastin) (1 trial)
capecitabine (xeloda) (2 trials)
cobicistat (stribild) (1 trial)
efavirenz (sustiva) (5 trials)
emtricitabine (emtriva) (2 trials)
etravirine (intelence) (2 trials)
fluorouracil (efudex) (1 trial)
interferon alpha-2b (Intron-A) (3 trials)
allogeneic adipose derived mesenchymal stem cell (5 trials)
autologous mesenchymal stem cells (1 trial)
carboplatin (paraplatin) (1 trial)
ceftriaxone (rocephin) (1 trial)
cytarabine (cytosar-u) (1 trial)
daunorubicin (cerubidine) (1 trial)
durvalumab (imfinzi) (1 trial)
fludeoxyglucose f-18 (1 trial)
Acquired Immunodeficiency Syndrome (Phase 4)
Adenocarcinoma (Phase 3)
Anemia (Phase 2)
Autoimmune Diseases (Phase 2)
Brain Diseases (Phase 4)
Breast Neoplasms (Phase 3)
Cardiac Output, Low (Phase 3)
Cardiomyopathies (Phase 3)
Cardiomyopathy, Dilated (Phase 3)
Cerebral Infarction (Phase 2)
Coinfection (Phase 4)
Colitis, Ulcerative (Phase 4)
Colonic Neoplasms (Phase 4)
Communicable Diseases (Phase 4)
Critical Illness (Phase 1)
Crohn Disease (Phase 4)
Cross Infection (Phase 3)
Desmoplastic Small Round Cell Tumor (Phase 2)
Disease (Phase 2)
Embolism (Phase 2)
Endocarditis (Phase 2)
Endocarditis, Bacterial (Phase 2)
Endocarditis, Subacute Bacterial (Phase 2)
Endometrial Neoplasms (Phase 2)
Fatty Liver (Phase 4)
Fecal Incontinence (Phase 2)
Fibromatosis, Aggressive (Phase 2)
Fibrosis (Phase 4)
Fractures, Bone (Phase 3)
Gingivitis (Phase 4)
Graft vs Host Disease (Phase 2)
Heart Failure (Phase 3)
Hepatic Encephalopathy (Phase 4)
Hepatitis (Phase 4)
Hepatitis A (Phase 4)
Hepatitis C (Phase 4)
Hepatitis C, Chronic (Phase 4)
Hepatitis, Chronic (Phase 4)
Hip Fractures (Phase 3)
HIV Infections (Phase 4)
Infections (Phase 4)
Influenza, Human (Phase 3)
Intraabdominal Infections (Phase 2)
Ischemia (Phase 2)
Leukemia (Phase 2)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Leukopenia (Phase 2)
Liver Cirrhosis (Phase 4)
Meningitis (Phase 4)
Meningitis, Pneumococcal (Phase 4)
Multiple Myeloma (Phase 2)
Multiple Sclerosis (Phase 2)
Neoplasm Metastasis (Phase 4)
Neoplasms (Phase 2)
Neoplasms, Plasma Cell (Phase 2)
Neoplasms, Second Primary (Phase 4)
Nervous System Diseases (Phase 2)
Neuroendocrine Tumors (Phase 2)
Non-alcoholic Fatty Liver Disease (Phase 2)
Osteosarcoma (Phase 2)
Pneumonia (Phase 3)
Pneumonia, Bacterial (Phase 3)
Prostatic Neoplasms (Phase 3)
Pseudomonas Infections (Phase 3)
Pulmonary Embolism (Phase 2)
Recurrence (Phase 3)
Respiration Disorders (Phase 2)
Respiratory Tract Diseases (Phase 2)
Sarcoma (Phase 2)
Sarcoma, Ewing (Phase 2)
Sclerosis (Phase 2)
Seizures (Phase 4)
Stroke (Phase 4)
Thrombocytopenia (Phase 2)
Thromboembolism (Phase 2)
Thrombosis (Phase 2)
Urinary Bladder Neoplasms (Phase 2)
Venous Thrombosis (Phase 2)
Viremia (Phase 2)